Another recent evidence of the clinical utility of the
high-power, short-duration radiofrequency ablation strategy
Koichiro Ejima, MD, PhD,1, 2 Kyoichiro Yazaki,
MD,1 Morio Shoda, MD, PhD, 1, 2Nobuhisa Hagiwara, MD, PhD 1
1. Department of Cardiology, Tokyo Women’s Medical University
2. Clinical Research Division for Heart Rhythm Management, Department of
Cardiology, Tokyo Women’s Medical University
Department of Cardiology, Tokyo Women’s Medical University, Tokyo, Japan
8-1, Kawada-cho, Shinjuku-ku, Tokyo, 162-8666 Japan
Funding : (None)
Disclosures : (None)
Corresponding author : Koichiro EjimaE-mail address :
koichiro@qf6.so-net.ne.jp
Department of Cardiology, Tokyo Women’s Medical University, Tokyo, Japan
8-1, Kawada-cho, Shinjuku-ku, Tokyo, 162-8666 Japan
Tel : +81-3-3353-8111 FAX : +81-3-3356-0441
Winkle et al. reviewed the literature of the high-power, short-duration
(HPSD) radiofrequency ablation strategy.1
We appreciate that they included our study that compared an HPSD
ablation with a low-power, long-duration (LPLD) ablation using unipolar
signal modification (USM) as a local endpoint during atrial fibrillation
(AF) ablation.2 This study included 32 patients
(paroxysmal 22, persistent 10) who underwent AF ablation using the HPSD
strategy and 32 using the LPLD, and the median follow-up period was 10
months.
After that, we reported another study that compared the HPSD ablation
with the LPLD ablation using the USM as a local endpoint during AF
ablation, which included only patients with paroxysmal
AF.3 The number of patients included in the study was
larger (HPSD 60, LPLD 60), and the follow-up duration was longer (mean
follow-up period of the HPSD group, 12.5 months) than that in our former
study. In this study, the freedom from recurrence after a single
ablation procedure without any antiarrhythmic drugs was higher in the
HPSD group than LPLD group (88.3% vs. 73.3% at 12-months after the
procedure, log-rank; P=0.0423). This article was electrically published
on May 15, 2020, more than 6 months before Winkle’s review article was
received by the editorial office of the Journal of Cardiovascular
Electrophysiology (December 4, 2020).
We believe that this study is also worth being included the Winkle’s
review article and might contribute to future investigators.